Results 51 to 60 of about 5,648,060 (295)
Plant Products as Antimicrobial Agents [PDF]
Clinical Microbiology Reviews, 1999 SUMMARY The use of and search for drugs and dietary supplements derived from plants have accelerated in recent years. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the Earth for phytochemicals and “leads” which could be developed for treatment of infectious diseases. While 25 to 50%
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Embryonal tumors comprise the majority of malignant central nervous system (CNS) neoplasms diagnosed in children under 3 years of age. Compared with their counterparts in older children, these tumors exhibit distinct molecular biology and a more aggressive clinical phenotype, while their management is complicated by the heightened ...
Sudarshawn Damodharan +3 more
wiley +1 more source
Ewing Sarcoma in Infants and Children Under 2 Years of Age: A French Retrospective Study
Pediatric Blood &Cancer, EarlyView.ABSTRACT Ewing sarcoma, the second most common primary bone cancer in children, requires intensive treatment that may lead to significant long‐term sequelae, particularly in infants. We retrospectively analyzed data from 1621 French patients treated between 1988 and 2015 within the EW88/93/97 or EE99 trials, focusing on 17 infants diagnosed before 24 ...
Elodie Verdier +18 more
wiley +1 more source
Ecology of plant volatiles: taking a plant community perspective [PDF]
, 2014 Although plants are sessile organisms, they can modulate their phenotype so as to cope with environmental stresses such as herbivore attack and competition with neighbouring plants.
Dicke, M. +10 more
core +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Pediatric thromboembolism is increasingly encountered in critical care. Systemic thrombolysis with tissue plasminogen activator (tPA) facilitates vessel or valve patency, yet pediatric‐specific protocols remain undefined, and safety concerns persist. Objective To evaluate the efficacy and safety of a tailored, prolonged systemic tPA
Eran Shostak +5 more
wiley +1 more source
A plant chamber system with downstream reaction chamber to study the effects of pollution on biogenic emissions [PDF]
, 2014 A system of two plant chambers and a downstream reaction chamber has been set up to investigate the emission of biogenic volatile organic compounds (BVOCs) and possible effects of pollutants such as ozone. The system can be used to compare BVOC emissions
Gankema, Paulien +6 more
core +1 more source
EFSA Journal, 2012 The PPR Panel was asked to deliver a scientific opinion on the science behind the development of a risk assessment of plant protection products on bees (Apis mellifera, Bombus spp. and solitary bees).
EFSA Panel on Plant Protection Products and their Residues (PPR)
doaj +1 more source
Plant production systems for vaccines
Expert Review of Vaccines, 2003 Plants offer an attractive alternative for the production and delivery of subunit vaccines. Various antigens have been expressed at sufficiently high levels in plants to render vaccine development practical. An increasing body of evidence demonstrates that these plant-produced antigens can induce immunogenic responses and confer protection when ...
Stephen J, Streatfield, John A, Howard
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT We assessed the effect of iron overload (IO) on mortality and complications following hematopoietic stem cell transplantation (HSCT) in patients with Diamond–Blackfan anemia syndrome (DBAS) in a systematic review of individual participant data and cohort data from observational studies.
Geoffrey Z. L. Kuppens +6 more
wiley +1 more source
EFSA Journal, 2010 The European Food Safety Authority (EFSA) asked the Panel on Plant Protection Products and their Residues (PPR) to develop an inventory of protected crop systems (e.g.
EFSA Panel on Plant Protection Products and their Residues (PPR)
doaj +1 more source